About Surface Ophthalmics
Surface Ophthalmics is a Healthcare company based in United States founded in 2020. Clinical development and research services for ophthalmology are provided. Surface Ophthalmics has raised $25 million across 1 funding round. Surface Ophthalmics offers products and services including Prescription Eye Drops and OTC Eye Drops. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its legal entity is Surface Ophthalmics, Inc. Its competitors include Ora Clinical, SpyGlass Ophthalmics and Trial Runners; 1 of its 3 listed competitors has raised funding.
Company details
Surface Ophthalmics was founded in 2020 and is based in the United States. Operations center on the ophthalmology sector, where clinical development and research services are offered to support pharmaceutical advancements. Expertise is applied in trial management, data analysis, and regulatory compliance for eye-related therapeutics. The focus remains on facilitating innovation through specialized outsourcing solutions in this niche field.
- Headquarters United States
- SectorsHealthcare
- Website surfaceophthalmics.com
- Social LinkedIn
- Legal Name Surface Ophthalmics, Inc.
- Total Equity Funding$25M (USD)
in 1 rounds
- Latest Funding Round$25M (USD), Series B
Jun 2021
Products & Services of Surface Ophthalmics
Surface Ophthalmics offers a comprehensive portfolio of products and services, including Prescription Eye Drops and OTC Eye Drops.
Treats dry eye syndrome with patented candidates for chronic symptoms.
Provides over-the-counter relief for episodic dry eye inflammation.
Funding Insights of Surface Ophthalmics
Surface Ophthalmics has successfully raised a total of $25M through 1 strategic funding round. The most recent funding activity was a Series B round of $25 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $25M
- Total Rounds 1
- Last Round Series B — $25M
- First Round $25M
(Jun 2021)
All 1 funding rounds of Surface Ophthalmics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2021 | $25M | Series B | – | – | – |
People of Surface Ophthalmics
1 people are tracked at Surface Ophthalmics (1 in leadership).
| Name | Role | Group |
|---|---|---|
Kam Hoss, MD, PhD | Healthcare entrepreneur; Co-Founder and CEO of Surface Ophthalmics, Inc. | Leadership |
Complete people profiles for Surface Ophthalmics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Surface Ophthalmics
2 dated milestones of Surface Ophthalmics across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Surface Ophthalmics is founded.
- Funding First funding round of $25.0M.
Competitors of Surface Ophthalmics
Surface Ophthalmics has 3 listed competitors in our database, 1 of them funded. They include Ora Clinical, SpyGlass Ophthalmics and Trial Runners.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| oraclinical.com | 1974 | Andover, United States | 346 | Provider of research and development services for ophthalmic drugs & devices | ||
| spyglassophthalmics.com | 2019 | Mission Viejo, United States | $33.53M | Drug research and development services for ophthalmic diseases are provided. | ||
| trialrunners.com | 2006 | Dickinson, United States | 57 | Specializes in ophthalmology clinical trials and contract research services. |
Detailed competitors of Surface Ophthalmics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Surface Ophthalmics
The website of Surface Ophthalmics (surfaceophthalmics.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▼ 4.4% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Surface Ophthalmics (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Surface Ophthalmics
Complete news archive for Surface Ophthalmics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Surface Ophthalmics
Surface Ophthalmics was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Surface Ophthalmics is headquartered in United States.
Surface Ophthalmics is a funded company, having raised a total of $25M across 1 funding round to date. The company's 1st funding round was a Series B of $25M, raised on Jun 2021.
Surface Ophthalmics was founded in 2020 and is based in the United States. Operations center on the ophthalmology sector, where clinical development and research services are offered to support pharmaceutical advancements. Expertise is applied in trial management, data analysis, and regulatory compliance for eye-related therapeutics. The focus remains on facilitating innovation through specialized outsourcing solutions in this niche field.
Surface Ophthalmics's top competitors include Ora Clinical, SpyGlass Ophthalmics and Trial Runners.
Surface Ophthalmics offers Prescription Eye Drops and OTC Eye Drops.
Surface Ophthalmics operates through Surface Ophthalmics, Inc..